| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 14 Jul 2026 | 14 Jul 2026 |
| Outcome of the Board Meeting held on Tuesday, July 14, 2026 and the disclosure pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015 regarding the approval of the Scheme of Amalgamation of Achyut Healthcare Limited with and into Zenith Healthcare Limited. After considering the recommendation of the Audit Committe and the Committe of Independent Directors of the Company, has inter-alia considered and approved a Scheme of Amalgamation of Achyut Healthcare Limited (Transferor Company) with and into Zenith Healthcare Limited (Transferee Company) and their respective shareholders and creditors (Scheme), under Section 230 to 232 and other applicable provisions of the Companies Act, 2013 (Act), rules and regulations made thereunder read with Section 2(6) of the Income Tax Act, 2025 for the aforementioned amalgamation, consequent dissolution of the Transferor Company without winding up and the issuance of quity shares by the Transferee Company to the equity shareholders of the Transferor Company as consideration. After considering the recommendation of the Audit Committee and the Committee of Independent Directors of the Company, has inter-alia considered and approved a Scheme of Amalgamation of Achyut Healthcare Limited (Transferor Company) with and into Zenith Healthcare Limited (Transferee Company) and their respective shareholders and creditors (Scheme), under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 (Act), rules and regulations made thereunder read with Section 2 (6) of the Income Tax Act, 2025, for the aforementioned amalgamation, consequent dissolution of the Transferor Company without winding up and the issuance of equity shares by the Transferee Company to the equity shareholders of the Transferor Company as consideration. | ||
| Board Meeting | 29 May 2026 | 19 May 2026 |
| Zenith Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve Zenith Healthcare Limited informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve We hereby inform you that the Board of Directors Meeting of Zenith Healthcare Limited is scheduled to be held on Friday May 29th 2026 at the registered office of the Company. Outcome of Board Meeting held on 29th May, 2026 for Consideration and Approval Audited Financial Result for the Quarter and Year ended 31st March, 2026 and other matters (As Per BSE Announcement Dated on:29.05.2026) | ||
| Board Meeting | 12 Feb 2026 | 2 Feb 2026 |
| Quarterly Results Un-Audited Financial Results For The Quarter Ended On 31St December, 2025 (As Per BSE Announcement Dated on: 12/02/2026) | ||
| Board Meeting | 11 Nov 2025 | 3 Nov 2025 |
| Zenith Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 inter alia to consider and approve Zenith Healthcare Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 inter alia to consider and approve the Un-Audited Financial Results for the quarter and half yearly ended September 30 2025 Unaudited Standalone Financial Results Of The Company Forthe Second Quarter And Half Year Ended 30 September2025 (As per BSE Announcement dated on: 11.11.2025) | ||
| Board Meeting | 1 Sep 2025 | 23 Aug 2025 |
| Zenith Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/09/2025 inter alia to consider and approve Intimation of Board Meeting to be held on Monday September 01 2025 Outcome of the Meeting of Board of Directors held on 01st September, 2025 (As Per BSE Announcement Dated on: 01/09/2025) | ||
| Board Meeting | 12 Aug 2025 | 4 Aug 2025 |
| Zenith Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 inter alia to consider and approve This is to inform you under Regulation 29 and any other Regulation of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 a Meeting of the Board of Directors of the Company will be held on TUESDAY 12th August 2025 at the Registered Office of the Company. Outcome of the Meeting of Board of Directors held on 12th August, 2025 (As Per BSE Announcement Dated on: 12/08/2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
